相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Heparanase mediates a novel mechanism in lapatinib-resistant brain metastatic breast cancer
Lixin Zhang et al.
NEOPLASIA (2015)
T Lymphocytes Redirected against the Chondroitin Sulfate Proteoglycan-4 Control the Growth of Multiple Solid Tumors both In Vitro and In Vivo
Claudia Geldres et al.
CLINICAL CANCER RESEARCH (2014)
p53 isoforms regulate aging- and tumor-associated replicative senescence in T lymphocytes
Abdul M. Mondal et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
CD19-Targeted T Cells Rapidly Induce Molecular Remissions in Adults with Chemotherapy-Refractory Acute Lymphoblastic Leukemia
Renier J. Brentjens et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
T cells redirected against HER2 for the adoptive immunotherapy for HER2-positive osteosarcoma
Nabil Ahmed et al.
CANCER RESEARCH (2012)
CD28 costimulation improves expansion and persistence of chimeric antigen receptor-modified T cells in lymphoma patients
Barbara Savoldo et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia
Michael Kalos et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Post-transcriptional regulation of heparanase gene expression by a 3′ AU-rich element
Gil Arvatz et al.
FASEB JOURNAL (2010)
Enhanced Tumor Trafficking of GD2 Chimeric Antigen Receptor T Cells by Expression of the Chemokine Receptor CCR2b
John A. Craddock et al.
JOURNAL OF IMMUNOTHERAPY (2010)
Epidermal Growth Factor-Induced Heparanase Nucleolar Localization Augments DNA Topoisomerase I Activity in Brain Metastatic Breast Cancer
Lixin Zhang et al.
MOLECULAR CANCER RESEARCH (2010)
Immunotherapy of Metastatic Melanoma Using Genetically Engineered GD2-Specific T cells
Eric Yvon et al.
CLINICAL CANCER RESEARCH (2009)
Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma
Martin A. Pule et al.
NATURE MEDICINE (2008)
Expression of the heparan sulfate-degrading enzyme heparanase is induced in infiltrating CD4+ T cells in experimental autoimmune encephalomyelitis and regulated at the level of transcription by early growth response gene 1
Amanda M. de Mestre et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2007)
T lymphocytes redirected against the κ light chain of human immunoglobulin efficiently kill mature B lymphocyte-derived malignant cells
Juan Vera et al.
BLOOD (2006)
A phase I study on adoptive immunotherapy using gene-modified T cells for ovarian cancer
Michael H. Kershaw et al.
CLINICAL CANCER RESEARCH (2006)
Tumor suppressor p53 regulates heparanase gene expression
L. Baraz et al.
ONCOGENE (2006)
The role of heparan sulphate in inflammation
Christopher R. Parish
NATURE REVIEWS IMMUNOLOGY (2006)
A chimeric T cell antigen receptor that augments cytokine release and supports clonal expansion of primary human T cells
MA Pulè et al.
MOLECULAR THERAPY (2005)
Immunosuppressive networks in the tumour environment and their therapeutic relevance
WP Zou
NATURE REVIEWS CANCER (2005)
Modulation of the heparanase-inhibiting activity of heparin through selective desulfation, graded N-acetylation, and glycol splitting
A Naggi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Antisense-mediated suppression of Heparanase gene inhibits melanoma cell invasion
M Roy et al.
NEOPLASIA (2005)
Trans-activation of heparanase promoter by ETS transcription factors
WC Lu et al.
ONCOGENE (2003)
分享论文
